Author

Eva Briem

Ludwig-Maximilians-Universität MünchenORCID 0009-0003-7506-3882Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Wolfgang EnardiD· 2 shared Alexander BarteltiD· 1 shared Anna Simone Jung· 1 shared Anna-Kristin Ludwig· 1 shared Christian WeberiD· 1 shared Daniel RichteriD· 1 shared Donato SantovitoiD· 1 shared Dorothee AtzleriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Wolfgang EnardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsiSciencePeer-reviewedJul 31, 2026

Improving RNA-seq protocols

Felix Pförtner, Eva Briem, Wolfgang Enard, Daniel Richter

The paper optimizes RNA-seq protocols to increase usable reads by 60% using a funnel strategy, improving cost-efficiency in bulk RNA-seq.

DOI 10.1016/j.isci.2026.116984

bulk RNA-seqstatistical model

𝕏 PostBluesky

ImmunologyAtherosclerosisPeer-reviewedDec 4, 2025

Galectin-1 induces macrophage immunometabolic reprogramming, modulates T cell immunity and attenuates atherosclerotic plaque formation

Ya Li, Julian Leberzammer, Xavier Blanchet…·Philipp von Hundelshausen

This study shows that Galectin-1 reduces atherosclerotic plaque formation by reprogramming macrophages and modulating T cell immunity through both glycan-dependent and -independent mechanisms.

3 citations

mouseproteomics

𝕏 PostBluesky